Nano Discovery LLC

[av_three_fourth first]

[av_textblock size=” font_color=” color=”]
Nano Discovery LLC is a bioassay company dedicated to the development of bioassays using nanotechnology tools. They develop and conduct immunoassays on a wide range of biomolecular targets for research and development needs. The core technology is a one-step homogeneous immunoassay method, nanoDLSAY that combines the use of gold nanoparticle optical probes with dynamic light scattering detection. This immunoassay is extremely easy to conduct, offers high sensitivity and requires small volumes of sample solutions for analysis.
[/av_textblock]

[av_button label=’website’ link=’manually,http://www.nanodiscoveryinc.com/’ link_target=’_blank’ size=’small’ position=’left’ icon_select=’no’ icon=’ue800′ font=’entypo-fontello’ color=’theme-color’ custom_bg=’#444444′ custom_font=’#ffffff’]

[/av_three_fourth][av_one_fourth]
[av_image src=’https://incubator.ucf.edu/wp-content/uploads/2015/04/dec3d1cb-a01a-4d43-9933-2ecb84181262.png’ attachment=’1063′ attachment_size=’full’ align=’center’ animation=’no-animation’ styling=” hover=” link=” target=” caption=” font_size=” appearance=” overlay_opacity=’0.4′ overlay_color=’#000000′ overlay_text_color=’#ffffff’][/av_image]
[/av_one_fourth]

more insights

DOE-backed scale-up of C-BATT’s Obsidia™ now underway

$1.25 million project moves American-made graphite alternative toward semicontinuous production and full-cell validation ORLANDO, Fla. (Aug. 12, 2026) — C-BATT and Semplastics today announced that manufacturing scale-up of Obsidia™, C-BATT’s domestically sourced lithium-ion

Read more >